CORAZZA, GINO ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 29.357
AS - Asia 22.410
EU - Europa 18.095
SA - Sud America 2.666
AF - Africa 729
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 29
AN - Antartide 1
Totale 73.332
Nazione #
US - Stati Uniti d'America 28.645
CN - Cina 11.727
SG - Singapore 4.731
IE - Irlanda 3.882
DE - Germania 2.503
UA - Ucraina 2.325
FI - Finlandia 2.289
HK - Hong Kong 2.101
BR - Brasile 1.978
RU - Federazione Russa 1.863
VN - Vietnam 1.696
IT - Italia 1.447
SE - Svezia 1.033
FR - Francia 1.026
GB - Regno Unito 789
IN - India 478
CA - Canada 439
ZA - Sudafrica 400
BD - Bangladesh 283
AR - Argentina 236
IQ - Iraq 198
JP - Giappone 183
MX - Messico 160
PL - Polonia 143
TR - Turchia 137
NL - Olanda 126
EC - Ecuador 112
BE - Belgio 107
CO - Colombia 103
ES - Italia 101
PK - Pakistan 92
ID - Indonesia 91
CZ - Repubblica Ceca 81
SA - Arabia Saudita 75
MA - Marocco 74
PH - Filippine 69
VE - Venezuela 65
UZ - Uzbekistan 58
MY - Malesia 54
JO - Giordania 52
PY - Paraguay 52
CL - Cile 51
TN - Tunisia 51
AT - Austria 50
LT - Lituania 44
PT - Portogallo 43
KE - Kenya 41
AZ - Azerbaigian 39
IR - Iran 37
EG - Egitto 36
IL - Israele 35
AU - Australia 32
DZ - Algeria 30
GR - Grecia 30
RO - Romania 30
AE - Emirati Arabi Uniti 27
BO - Bolivia 26
AL - Albania 24
CH - Svizzera 24
PE - Perù 24
EU - Europa 23
JM - Giamaica 22
LB - Libano 22
KZ - Kazakistan 21
OM - Oman 21
ET - Etiopia 20
KG - Kirghizistan 19
NP - Nepal 19
MU - Mauritius 18
TH - Thailandia 17
CR - Costa Rica 16
LV - Lettonia 16
RS - Serbia 16
SY - Repubblica araba siriana 15
UY - Uruguay 15
BY - Bielorussia 14
PS - Palestinian Territory 14
GE - Georgia 13
HN - Honduras 13
MD - Moldavia 13
KR - Corea 12
NZ - Nuova Zelanda 12
BG - Bulgaria 11
PA - Panama 11
DO - Repubblica Dominicana 10
SK - Slovacchia (Repubblica Slovacca) 10
BH - Bahrain 9
HU - Ungheria 9
NG - Nigeria 9
SN - Senegal 9
LA - Repubblica Popolare Democratica del Laos 8
SV - El Salvador 8
DK - Danimarca 7
KW - Kuwait 7
NI - Nicaragua 7
AM - Armenia 6
BS - Bahamas 6
GT - Guatemala 6
HR - Croazia 6
KH - Cambogia 6
Totale 73.194
Città #
Dublin 3.875
Chandler 3.752
San Jose 3.285
Jacksonville 3.140
Nanjing 2.580
Singapore 2.419
Ashburn 2.357
Hong Kong 2.048
Dallas 2.019
Beijing 1.827
Boardman 1.131
Nanchang 1.046
Munich 834
Princeton 821
Helsinki 800
Wilmington 769
Hebei 755
Lawrence 748
Shenyang 747
Lauterbourg 699
Los Angeles 698
Changsha 683
Jiaxing 602
Ho Chi Minh City 575
Medford 548
New York 540
Tianjin 443
Hangzhou 430
Ann Arbor 428
Hanoi 412
Moscow 351
Johannesburg 335
Council Bluffs 327
Shanghai 327
Buffalo 313
Redondo Beach 303
Milan 298
Toronto 221
São Paulo 196
Dearborn 194
Woodbridge 185
Turku 178
Santa Clara 167
Tokyo 165
Orem 158
Norwalk 152
Pavia 138
Fairfield 123
Warsaw 121
Verona 106
Frankfurt am Main 105
Houston 104
Brussels 103
Brooklyn 101
Montreal 100
Pune 99
Chennai 96
Seattle 95
San Francisco 93
Chicago 92
Da Nang 87
London 75
Guangzhou 74
Kunming 73
Baghdad 72
Jinan 69
Falkenstein 67
Atlanta 66
Stockholm 62
Rio de Janeiro 61
Des Moines 59
Haiphong 59
Denver 58
Phoenix 58
Rome 58
Brno 56
Amsterdam 54
The Dalles 54
Boston 53
Zhengzhou 53
Mexico City 52
Ningbo 49
Ankara 48
Cambridge 48
Quito 48
Tashkent 48
Amman 47
Manchester 45
Poplar 44
Biên Hòa 43
Nuremberg 40
Taizhou 40
Turin 38
Washington 38
Dhaka 36
Palermo 36
Paris 36
Belo Horizonte 35
Nairobi 35
Baku 34
Totale 48.465
Nome #
A new "three seamples" method to detect lactose malabsorption by H2 breath testing 303
A gluten-free diet questionnaire compared to persistence of villous atrophy and endomysial antibody. 293
A gluten-free diet questionnaire compared to persistence of villous atrophy and endomysial antibody 285
Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease 265
Rugarli - Medicina interna sistematica - Malattie dell'apparato digerente 229
A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions 228
Peripheral blood dendritic cells in coeliac disease 226
Study of the microbiota composition in adult celiac disease 191
Harrison Principi di Medicina Interna, 18a Edizione 188
A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. 186
A new approach to diagnosis of intestinal graft-versus-host disease by transabdominal high-resolution ultrasonography and colour doppler imaging 180
A consensus for the development of a vector model to assess clinical complexity 180
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 177
Infliximab e marker sierici di fibrosi nel morbo di Crohn. 173
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 165
Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease 165
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas. 164
Anemia and erythropoiesis in untreated coeliac disease 164
Cytokine genetic profile in Whipple's disease 163
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 163
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 162
Malattia di Crohn fistolizzante - Nuovo approccio terapeutico con le cellule staminali 161
A double colour immuno-fluorescence co-localization study of EMA+ve/TTA-ve coeliac sera and anti-tTG moAb 158
La malattia celiaca 156
Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome. 155
Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease 153
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 152
Metalloproteinasi di matrice e tratto gastrointestinale 151
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 151
A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? 150
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 149
Abnormal anandamide metabolism in celiac disease. 149
Induzione e mantenimento di remissione clinica mediante l’utilizzo di Budesonide in paziente affetto da malattia di Crohn ad esordio giovanile, a localizzazione ileo-colonica e fenotipo steno-fistolizzante, già sottoposto a terapia immunosoppressiva, biologica, cellulare e chirurgica. 148
A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study 148
Intraepithelial lymphocytes in the villous tip: do they indicate potential coelic disease? 146
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. 146
A comparison of the screening power of endomysial and tissue transglutaminase antibodies in coeliac disease 146
The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. 144
Immunosuppressive effect of bone marrow-derived mesenchymal stromal cells on gliadin-specific T cell lines 143
A case of fever of unknown origin? 143
Effect of tumor necrosis factor-alpha blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease 143
A milligram of gluten a day keeps the mucosal recovery way 143
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma 142
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 142
A reassessment of splenic hypofunction in celiac disease. 141
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 141
A non toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? 141
A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. 141
Validation and cross-cultural adaptation of the Italian translation of the Inflammatory Bowel Disease Questionnaire in patients with Crohn's disease or Ulcerative Colitis. 140
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. 139
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 138
Correlation between mucosal levels of receptor for advanced glycation end products (RAGE) with inflammatory indexes in crohn's disease and ulcerative colitis 137
Mitochondrial dysfunction in Crohn disease: possible role of reactive oxygen species 137
Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease 137
Long-Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric Series 136
Coeliac disese in first degree relatives: an incidence study 136
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 136
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 136
Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy? 135
Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: Analysis of 200 cases with extended follow-up 135
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease 134
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 133
Increased expression of mucosal addressin cell adhesion molecule-1 in the duodenum of patients with active celiac disease is associated with depletion of integrin α4β7-positive T cells in blood. 133
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 132
Bone mass and metabolism in dermatitis herpetiformis 131
A one minute questionnaire to evaluate the compliance to a gluten-free diet. 131
A milligram of gluten a day keeps the mucosal recovery away: a case report. 131
A comparison of the screening power of endomysial and tissue transglutaminase antibodies in coeliac disease 131
Apoptosis and peripheral blood lymphocyte depletion in coeliac disease. 130
Aquaporins and solute transporters are decreased in coeliac disease 130
Malattia di Crohn: novità e prospettive della terapia. 130
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 130
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 130
Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome. 129
Herbay classification applied to Italian patients with Whipple's disease 129
Cerebellar signs in celiac disease. 129
An unconventional case of scurvy. 129
Phenotypical and functional characterization of bone marrow-derived mesenchymal stromal cells from patients with Crohn’s disease 128
HLA DQ2 and DQ8 homozygosity in patients with potential coeliac disease 128
Absence of a role for interleukin-13 in inflammatory bowel disease 128
Bones in coeliac disease: diagnosis and treatment 127
Genetic test for lactase non-persistence and hydrogen breath test: is genotype better than phenotype to diagnose lactose malabsorption? 127
Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma. 127
HLA clas I and II in patients with Whipple's disease 127
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 127
Italian translation, cultural adaptation and initial statistical validation of the inflammatory bowel disease questionnaire 127
An Italian multicentric study on complicated coeliac disease 127
From impending toxic megacolon to multiple organ failure in severe ulcerative colitis 127
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Products Inversely Correlate With Disease Activity Indexes In Patients With Inflammatory Bowel Disease 127
Bortezomib-induced paralytic ileus is a potential gastrointestinal side-effect of this first-in-class anti-cancer proteasome inhibitor 126
IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients. 126
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 126
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 126
Video capsule endoscopy and histology for small-bowel mucosa evaluation: a comparison performed by blinded observers. 125
Le cellule staminali quale potenziale strategia terapeutica nelle malattie infiammatorie croniche 125
Doppler enhancement after intravenous levovist injection in Crohn's disease 124
Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome. 124
Interferon therapy for chronic hepatitis virus c infection is not associated to an increased risk to develop coeliac disease 124
Association between defective spleen function and primary eosinophilic gastrointestinal disorders 124
Totale 15.013
Categoria #
all - tutte 303.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 303.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.113 37 14 151 28 34 48 54 197 172 116 556 1.706
2022/202311.118 1.283 849 104 748 1.146 1.089 56 643 4.648 127 279 146
2023/20243.690 521 639 111 281 354 1.038 75 262 20 130 131 128
2024/202510.931 224 896 362 404 205 621 630 874 2.656 307 1.157 2.595
2025/202624.502 1.907 1.633 2.762 2.577 2.845 1.102 4.894 1.085 2.233 1.844 843 777
2026/2027179 179 0 0 0 0 0 0 0 0 0 0 0
Totale 74.328